mHealth Intervention to Improve Treatment Outcomes Among People With HIV Who Use Cocaine: Protocol for a Pilot

Yerina S Ranjit1, Archana Krishnan, Debarchana Ghosh2

  • 1Department of Communication, University of Missouri, Columbia, MO, United States.

Insights

This study tested a mobile health intervention using smart pillboxes and smartphones to improve medication adherence for people with HIV who use cocaine. The intervention aimed to overcome challenges in engaging high-risk populations in HIV care.

Area of Science:

  • Digital health interventions
  • HIV/AIDS research
  • Substance use disorder treatment

Background:

  • Antiretroviral therapy (ART) is crucial for managing HIV, but adherence is challenging, especially for individuals with substance use disorders.
  • People with HIV who use cocaine often face barriers to consistent HIV care and lower retention rates.
  • Improving medication adherence is critical for successful HIV treatment outcomes and reducing transmission.

Purpose of the Study:

  • To describe a mobile health (mHealth) intervention designed to enhance ART adherence among people with HIV who use cocaine.
  • To identify and discuss challenges and adaptations in the study design for this population.
  • To provide insights into implementing complex mHealth interventions for marginalized groups.

Main Methods:

  • Project SMART utilized a 12-week pilot randomized controlled trial with a wireless technology-based intervention.
  • Intervention components included cellular-enabled electronic pillboxes (TowerView Health) and smartphones for adherence reminders and feedback.
  • The study design was informed by Self-Determination Theory and the Motivation Technology Model, incorporating automated, clinician-assisted, and social network feedback arms.

Main Results:

  • The study enrolled 71 participants, with 80% (57) completing the 12-week intervention.
  • Data collection occurred between June 2017 and January 2020.
  • Full study results are currently undergoing analysis, with publication anticipated in early 2022.

Conclusions:

  • Implementing mHealth interventions for high-risk populations presents significant challenges, including technological access, financial stability, and minimizing participant burden.
  • Feasibility studies are essential for identifying and addressing these challenges proactively.
  • Adapting intervention designs to maintain the integrity of randomized controlled trials is crucial for generating reliable evidence.
Abstract

Related Concept Videos

Community Based Intervention01:30

Community Based Intervention

Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
104
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
47.3K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
358